EMERGENT BIOSOLUTIONS INC. COMMON STOCK

Emergent BioSolutions Reports First Quarter 2024 Financial Results

01 مايو 2024 16:57:22 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position

01 مايو 2024 16:10:00 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

01 مايو 2024 11:03:28 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

30 أبريل 2024 17:26:55 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024

22 أبريل 2024 08:05:00 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

28 مارس 2024 08:15:03 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

25 مارس 2024 08:05:00 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

06 مارس 2024 16:31:01 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

29 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

21 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

06 فبراير 2024 09:45:22 بحسب NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

05 فبراير 2024 09:47:20 بحسب NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

02 فبراير 2024 09:47:25 بحسب NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

01 فبراير 2024 09:45:21 بحسب NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

31 يناير 2024 09:45:41 بحسب NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

30 يناير 2024 12:27:22 بحسب NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

29 يناير 2024 09:53:19 بحسب NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

19 يناير 2024 09:46:42 بحسب NetDania Notify

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

11 يناير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

09 يناير 2024 07:30:00 بحسب Nasdaq GlobeNewswire